18 results
424B5
MLYS
Mineralys Therapeutics Inc
11 Apr 24
Prospectus supplement for primary offering
4:35pm
outstanding under our 2023 Incentive Award Plan (the 2023 Plan), at a weighted-average exercise price of $15.16 per share;
1,088,294 shares of common … stock issuable upon the exercise of stock options outstanding under our 2020 Equity Incentive Plan (the 2020 Plan), at a weighted-average exercise
DEF 14A
MLYS
Mineralys Therapeutics Inc
9 Apr 24
Definitive proxy
7:15am
)
Stock Awards
($)(4)
Non-Equity
Incentive Plan
Compensation
($)(5)
All Other
Compensation
($)(6)
Total
Jon Congleton
Chief Executive Officer
Adam Levy … of the common stock underlying such awards. See “—Narrative to Summary Compensation Table—Equity-Based Incentive Awards.”
(4)The amounts reported in the “Stock
S-3
MLYS
Mineralys Therapeutics Inc
21 Mar 24
Shelf registration
7:30am
were outstanding under our 2023 Incentive Award Plan and options to purchase 1,088,294 shares of our common stock were outstanding under our 2020 … Equity Incentive Plan.
Registration Rights
Purchase Agreement
Under our Purchase Agreement, dated February 7, 2024, with the purchasers named therein
10-Q
6j27iwx7 8t1im
15 May 23
Quarterly report
5:25pm
DRS/A
v202 a8bj
29 Dec 22
Draft registration statement (amended)
12:00am
DRS/A
ru77kf96v2u vj
7 Dec 22
Draft registration statement (amended)
12:00am
DRS
EX-10.1
gcfxjbmn3gu6p ktg6pc
4 Nov 22
Draft registration statement
12:00am
DRS
EX-10.5
7r5wx3kmy hdb
4 Nov 22
Draft registration statement
12:00am
DRS
zzi2 l744bbmu2ppplk5
4 Nov 22
Draft registration statement
12:00am
DRS
EX-4.2
5v389wi94
4 Nov 22
Draft registration statement
12:00am
DRS
EX-10.7
l3j85mjtr7 cly
4 Nov 22
Draft registration statement
12:00am
DRS
EX-10.6
x7fp0r 98ceqh9
4 Nov 22
Draft registration statement
12:00am
- Prev
- 1
- Next